Pharmaceutical giant Pfizer ended the development of an experimental daily weight loss pill after one patient experienced a potential side effect.
A patient reportedly had a liver injury possibly caused by the drug in the trial.
“Interesting. Are the rules different for vaccines,” Children’s Health Defense commented.
Interesting.
Trending: Michelle Obama Addresses Bombshell Divorce Rumors: ‘I’m Choosing Me’
Are the rules different for vaccines, @pfizer? pic.twitter.com/XvLWCoCYiM
— Children’s Health Defense (@ChildrensHD) April 14, 2025
Per CNBC:
The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in a statement. They added that the patient’s liver enzymes “recovered rapidly” after they stopped taking the pill, which is an oral GLP-1 drug called danuglipron. The statement suggests that the patient’s liver enzymes were elevated, which often indicates damage
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!